GLP-1s are serious medications with certain potential toxicities for some patients, including pancreatitis, thyroid cancer, and very rarely, but now officially acknowledged in the case of Wegovy blindness, caused by a condition called non-arteritic anterior ischemic optic neuropathy (NAION)
In contrast, BRP appears to act specifically in the hypothalamus, which controls appetite and metabolism. Svensson has co-founded a company to launch clinical trials of the molecule in humans in the near future
If not properly managed, it can lead to serious complications such as heart disease, kidney damage, vision loss, stroke, and even limb amputation
The extended timelines necessary to study narrative development across the lifespan make such research difficult to conduct and fund
Diabetes Care 36 , 24562465 (2013)
Typical 2D class averages are shown in Supplementary Fig